Product Description
Elravie® Premier Product Overview
Elravie® Premier is a high-purity hyaluronic acid (HA) dermal filler developed using innovative technologies such as the HI Method (High Molecular Ideal Reticulated Matrix). This filler offers enhanced durability, cohesiveness, and biocompatibility. With a broad range of applications, Elravie Premier provides effective solutions for wrinkle reduction, volume restoration, and skin rejuvenation while maintaining a natural look and feel. It is especially valued for its 18-month duration of effect with a single re-touch.
Key Features:
- Type: Monophasic volumizing filler
- Ingredients: Pharmaceutical-grade hyaluronic acid
- Technologies: HI Method for high cross-linking efficiency and NIA (Non-Inflammation Asepsis) for purification
- Duration: Lasts up to 18 months with one re-touch.
Elravie® Premier Indications for Use
Elravie Premier is designed for a variety of aesthetic applications, targeting both deep wrinkles and areas requiring volume enhancement.
Primary Indications:
- Nasolabial Folds: Effective for moderate to severe wrinkles in this region.
- Cheek and Jawline Contouring: Restores volume and defines facial contours.
- Skin Rejuvenation: Improves elasticity and firmness while hydrating the dermis.
- Wrinkle Severity Reduction: Reduces visible fine lines and deep folds.
Elravie® Premier Dosage Information
Elravie Premier is administered via injection, requiring precise techniques to ensure patient safety and efficacy.
Treatment Protocols:
- Injection Sites: Tailored to the treated area (e.g., nasolabial folds, cheeks, jawline).
- Needle Type: Provided with a thin-walled (TW) needle or compatible cannula for smoother application.
- Session Frequency: A single session can achieve significant results; re-touch is advised at 9 months to extend effects up to 18 months.
Elravie® Premier Side Effects and Precautions
Elravie Premier demonstrates a favorable safety profile due to its biocompatible formulation. However, like all injectable treatments, minor side effects may occur.
Common Side Effects:
- Swelling and Redness: Localized at the injection site, typically resolves within 48 hours.
- Bruising: Mild and temporary, particularly in sensitive areas.
- Discomfort: Minimal due to the inclusion of lidocaine in some variants.
Precautions:
- Aseptic Handling: Essential to prevent infection.
- Avoid in Active Skin Conditions: Do not use on inflamed or infected areas.
- Allergy Screening: Patients with known HA sensitivities should be tested.
- Post-Treatment Care: Patients should avoid intense physical activities and exposure to heat or sun for 24-48 hours.
Elravie® Premier Clinical Studies or Real-World Outcomes
Extensive clinical data support the efficacy and longevity of Elravie Premier, with studies highlighting its 18-month duration and superior patient satisfaction.
Key Findings:
- Wrinkle Severity Reduction: Achieves significant improvement in Wrinkle Severity Rating Scale (WSRS) within 3 months, with sustained results through maintenance.
- Volume Restoration: Provides natural-looking contour enhancement and long-term stability.
- High Patient Satisfaction: Studies indicate a 96.6% preference for HA fillers with lidocaine due to reduced pain and fewer side effects.
Clinical Observations:
- Pain Relief: Patients experience 50% less pain during and after treatment with lidocaine-containing formulations.
- Long-Lasting Effects: Benefits persist up to 18 months with a single re-touch.
Elravie® Premier Composition and Active Ingredients
Elravie Premier uses pharmaceutical-grade hyaluronic acid processed through advanced technologies for purity and performance.
Key Components:
- Hyaluronic Acid: High-molecular-weight, cross-linked HA ensures volume retention and durability.
- NIA Method Purification: Removes endotoxins, proteins, and inflammatory substances to enhance safety and minimize side effects.
- HI Method: Optimizes the cross-linking process, improving filler cohesiveness and resistance to deformation.
Elravie® Premier Drug Interactions
Elravie Premier is localized, minimizing systemic absorption and potential drug interactions.
Considerations:
- Concurrent Aesthetic Procedures: Can be combined with laser treatments or microneedling, spaced two weeks apart.
- Anticoagulants: Increased risk of bruising in patients taking blood-thinning medications.
Immunosuppressive Therapy: Use cautiously due to potential delays in healing.
